Fact CheckerSign in

NCT07117539Completed

Impact of Different Lung Isolation Devices on Pharyngolaryngeal Injuries After Pulmonary Resection

Impact of Laryngeal Mask Combined With Visual Bronchial Blocker on Pharyngolaryngeal Injuries After Pulmonary Resection

Source: ClinicalTrials.gov · Last updated 15 Jan 2026

Brief summary (registry, in English)

The goal of this clinical trial is to assess the impact of laryngeal mask combined with visual bronchial blocker on pharyngolaryngeal injury after pulmonary resection in patients with pulmonary nodules. The main question it aims to answer is: the incidence of postoperative pharyngolaryngeal injury within 24h : sore throat and hoarseness ? Researchers will compare the visual bronchial blocker group (VBB) with the double-lumen endotracheal tube group (DLT) to see if the visual bronchial blocker group can minimize laryngopharyngeal injury after pulmonary resection.

Status (registry)
Completed
Study type
Interventional
Enrollment
270 (actual)
First submitted
16 Jul 2025
Start date
18 Aug 2025
Primary completion date
31 Oct 2025
Lead sponsor
Tingting Li
NCT number
NCT07117539

What you commit to

  • Study type: Interventional
  • Participants enrolled: 270
  • From 18 Aug 2025 to the primary completion date, 31 Oct 2025
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Anticipated difficult airway (Mallampati class IV, previous difficult intubation, airway abnormalities)
  • Previous lung surgery or bilateral lung surgery

Other illness

  • Gastroesophageal reflux disease or gastric retention
  • Active pulmonary infection or bleeding
  • Cognitive impairment affecting outcome assessment
  • Any condition deemed unsuitable for study participation by anesthesiologist or surgeon

Other

  • Severe pulmonary dysfunction (FEV1 \<50% predicted)
  • Chronic throat pain or voice abnormalities within 24 hours preoperatively
  • Abnormal right upper lobe bronchial anatomy on preoperative CT for right-sided procedures

Who the study is looking for

  • Age ≥18 years
  • Scheduled for elective VATS pulmonary resection under general anesthesia
  • American Society of Anesthesiologists (ASA) physical status I-III
  • Body mass index (BMI) 18.5-30.0 kg/m²
  • Written informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
The Second Military Medical University Changhai Hospital
Coordinator of this site? Confirm its status
ShanghaiChinaUnknown status
Shanghai Chest Hospital
Coordinator of this site? Confirm its status
ShanghaiChinaUnknown status
Shanghai Pulmonary Hospital
Coordinator of this site? Confirm its status
ShanghaiChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.